+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
COPD & Asthma Devices Market by Product Type, Application, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
COPD & Asthma Devices Market by Product Type, Application, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

COPD & Asthma Devices Market by Product Type, Application, End-User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011571
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The COPD & Asthma Devices Market grew from USD 35.33 billion in 2023 to USD 37.45 billion in 2024. It is expected to continue growing at a CAGR of 5.93%, reaching USD 52.90 billion by 2030.

The scope of COPD & Asthma Devices encompasses therapeutic and diagnostic devices used for managing Chronic Obstructive Pulmonary Disease and asthma. These devices include inhalers, nebulizers, peak flow meters, and spirometers that are pivotal in patient care by facilitating drug delivery and improving patient monitoring. The necessity of these devices is underscored by increasing global incidences of respiratory disorders due to pollution and lifestyle changes, highlighting the essential role in enhancing patient compliance and health outcomes. Applications are vast, from homecare settings to clinical environments, catering to both preventive and management needs. End-use sectors primarily include hospitals, clinics, homecare, and emergency medical services. Key growth influencers are rising disease prevalence, innovation in drug delivery systems, and technological advancements in medical devices. The increased focus on digital health, such as the integration of smart inhalers and artificial intelligence, embodies potential opportunities for stakeholders to enhance product offerings and patient engagement. The expansion of telemedicine also provides avenues for market growth. Nonetheless, challenges such as regulatory hurdles, high device costs, and limited healthcare access in emerging economies can impede growth. Areas for innovation include enhanced biomarker-based diagnostic devices, AI-powered respiratory monitoring systems, and personalized therapeutic solutions that cater to varying degrees of disease severity. However, the nature of the market is competitive, driven by continuous technological innovation and a need for cost-effective solutions. Companies can capture market potential by investing in R&D for novel therapeutics and devices, forming strategic alliances for distribution expansion, and engaging in patient-centric design to improve usability and adherence. Remaining cognizant of regulatory trends and market dynamics will be essential for navigating the complexities and capitalizing on opportunities within this critical healthcare segment.

Understanding Market Dynamics in the COPD & Asthma Devices Market

The COPD & Asthma Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Government initiatives and policies supporting respiratory disease management and treatment
    • Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
    • Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
    • Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
  • Market Restraints
    • Lack of standardization in COPD & asthma device manufacturing affecting product consistency
    • Challenges in educating healthcare providers about the latest COPD & asthma device advancements
  • Market Opportunities
    • Rise of personalized medicine approaches in COPD and asthma treatment protocols
    • Growth in patient education and self-management programs to reduce asthma-related hospitalizations
    • Innovative drug delivery systems enhancing medication adherence in COPD treatments
  • Market Challenges
    • Complications in ensuring patient adherence and compliance with prescribed treatment regimens
    • Limited healthcare access in rural and underserved areas

Exploring Porter’s Five Forces for the COPD & Asthma Devices Market

Porter’s Five Forces framework further strengthens the insights of the COPD & Asthma Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the COPD & Asthma Devices Market

External macro-environmental factors deeply influence the performance of the COPD & Asthma Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the COPD & Asthma Devices Market

The COPD & Asthma Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the COPD & Asthma Devices Market

The COPD & Asthma Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the COPD & Asthma Devices Market

The COPD & Asthma Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the COPD & Asthma Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Health Care, Aerogen, Air Liquide Healthcare, Becton, Dickinson and Company, Chart Industries, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, GF Health Products, Inc., Hamilton Medical, Invacare Corporation, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, PARI Medical Holding, ResMed, Smiths Medical, SunMed, and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the COPD & Asthma Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Accessories
      • Actuators
      • Dry Powder Inhaler Rotacaps & Cartridges
      • Spacers
    • Inhalers
      • Dry Powder Inhalers (DPI)
      • Metered-Dose Inhalers (MDI)
      • Soft Mist Inhalers
    • Nebulizers
      • Jet Nebulizers
      • Mesh Nebulizers
      • Ultrasonic Nebulizers
  • Application
    • Asthma
      • Allergic Asthma
      • Exercise-Induced Asthma
      • Non-Allergic Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
      • Chronic Bronchitis
      • Emphysema
  • End-User
    • Ambulatory Surgical Centers
    • Homecare Settings
    • Hospitals & Clinics
    • Specialty Clinics
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government initiatives and policies supporting respiratory disease management and treatment
5.1.1.2. Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
5.1.1.3. Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
5.1.1.4. Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
5.1.2. Restraints
5.1.2.1. Lack of standardization in COPD & asthma device manufacturing affecting product consistency
5.1.2.2. Challenges in educating healthcare providers about the latest COPD & asthma device advancements
5.1.3. Opportunities
5.1.3.1. Rise of personalized medicine approaches in COPD and asthma treatment protocols
5.1.3.2. Growth in patient education and self-management programs to reduce asthma-related hospitalizations
5.1.3.3. Innovative drug delivery systems enhancing medication adherence in COPD treatments
5.1.4. Challenges
5.1.4.1. Complications in ensuring patient adherence and compliance with prescribed treatment regimens
5.1.4.2. Limited healthcare access in rural and underserved areas
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. COPD & Asthma Devices Market, by Product Type
6.1. Introduction
6.2. Accessories
6.2.1. Actuators
6.2.2. Dry Powder Inhaler Rotacaps & Cartridges
6.2.3. Spacers
6.3. Inhalers
6.3.1. Dry Powder Inhalers (DPI)
6.3.2. Metered-Dose Inhalers (MDI)
6.3.3. Soft Mist Inhalers
6.4. Nebulizers
6.4.1. Jet Nebulizers
6.4.2. Mesh Nebulizers
6.4.3. Ultrasonic Nebulizers
7. COPD & Asthma Devices Market, by Application
7.1. Introduction
7.2. Asthma
7.2.1. Allergic Asthma
7.2.2. Exercise-Induced Asthma
7.2.3. Non-Allergic Asthma
7.3. Chronic Obstructive Pulmonary Disease (COPD)
7.3.1. Chronic Bronchitis
7.3.2. Emphysema
8. COPD & Asthma Devices Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Homecare Settings
8.4. Hospitals & Clinics
8.5. Specialty Clinics
9. COPD & Asthma Devices Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas COPD & Asthma Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific COPD & Asthma Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa COPD & Asthma Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. COPD & ASTHMA DEVICES MARKET RESEARCH PROCESS
FIGURE 2. COPD & ASTHMA DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. COPD & ASTHMA DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. COPD & ASTHMA DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. COPD & ASTHMA DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COPD & ASTHMA DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALER ROTACAPS & CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPACERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALERS (DPI), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY METERED-DOSE INHALERS (MDI), BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EXERCISE-INDUCED ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NON-ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EMPHYSEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 49. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 68. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 72. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 73. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 74. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 76. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 77. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 81. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 85. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 86. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 119. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 120. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 121. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 123. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 124. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 128. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 129. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 130. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 132. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 133. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 142. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 146. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 147. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 148. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 150. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 151. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 196. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 200. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 201. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 202. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 204. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 205. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 214. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 226. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 228. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 229. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 230. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 232. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 233. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 237. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 238. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 239. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 241. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 242. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 246. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 247. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 248. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 250. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 251. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 255. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 256. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 257. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 259. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 260. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 264. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 265. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 266. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 268. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 269. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 278. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 282. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 283. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 284. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 286. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 287. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 305. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 309. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 310. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 311. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 313. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 314. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 318. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 319. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 320. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 322. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 323. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 327. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 328. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 329. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 331. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
TABLE 332. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 333. QATAR COPD

Companies Mentioned

The leading players in the COPD & Asthma Devices market, which are profiled in this report, include:
  • 3M Health Care
  • Aerogen
  • Air Liquide Healthcare
  • Becton, Dickinson and Company
  • Chart Industries
  • Drive DeVilbiss Healthcare
  • Fisher & Paykel Healthcare
  • Getinge
  • GF Health Products, Inc.
  • Hamilton Medical
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • PARI Medical Holding
  • ResMed
  • Smiths Medical
  • SunMed
  • Teleflex Incorporated

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 37.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 52.9 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2024 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2024

  • Report
  • 175 Pages
  • Global
From
COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2024-2032 - Product Image

COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
COPD and Asthma Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

COPD and Asthma Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 112 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From

About the COPD and Asthma Device Market

The COPD and Asthma Device market is a subset of the larger Respiratory Device market. It includes devices used to diagnose, monitor, and treat chronic obstructive pulmonary disease (COPD) and asthma. These devices range from inhalers and nebulizers to pulse oximeters and spirometers. Inhalers are used to deliver medication directly to the lungs, while nebulizers are used to convert liquid medication into a mist that can be inhaled. Pulse oximeters measure oxygen levels in the blood, while spirometers measure lung capacity. The COPD and Asthma Device market is driven by the increasing prevalence of COPD and asthma, as well as technological advancements in the field. Companies in this market include Philips, ResMed, Fisher & Paykel, and Masimo. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.